Back
Molecular Partners AG 10K Form
Buy
53
MOLN
Molecular Partners AG
Last Price:
$4.60
Seasonality Move:
28.84%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MOLN News And Ratings
See the #1 stock for the next 7 days that we like better than MOLN
MOLN Financial Statistics
Sales & Book Value
| Annual Sales: | $5.6M |
|---|---|
| Cash Flow: | $-12.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.21 |
| Price / Book: | 1.39 |
Profitability
| EPS (TTM): | -1.90910 |
|---|---|
| Net Income (TTM): | $-70.9M |
| Gross Margin: | $0 |
| Return on Equity: | -49.28% |
| Return on Assets: | -43.56% |
Molecular Partners AG Earnings Forecast
Key Molecular Partners AG Financial Ratios
-
The Gross Profit Margin over the past 14 years for MOLN is 0.00%.
-
The Selling, General & Administrative Expenses for MOLN have been equal to 353.78% of Gross Profit Margin.
-
The Research & Development expenses have been 938.72% of Revenue.
-
The Net Earning history of MOLN is -1,087.39% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 6 years.
Molecular Partners AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MOLN |
| Website: | molecularpartners.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 9.28 |
| Quick Ratio: | 9.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MOLN Technical Analysis vs Fundamental Analysis
Buy
53
Molecular Partners AG (MOLN)
is a Buy
Is Molecular Partners AG a Buy or a Sell?
-
Molecular Partners AG stock is rated a BuyThe current Molecular Partners AG [MOLN] share price is $4.45. The Score for MOLN is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.